Pharmacy Pearls: COVID-19 Antiviral Therapies

Home › News › Pharmacy Pearls: COVID-19 Antiviral Therapies

Pharmacy Pearls: COVID-19 Antiviral Therapies

January 26th, 2022 | COVID-19 Pharmacy Pearl•Pharmacy Pearls•Infectious Diseases
In this edition of Pharmacy Pearls, we review the two new outpatient COVID-19 antiviral treatment options under EUA, Paxlovid™ and molnupiravir. Place in therapy, indications for use, clinical data, dosing and therapy considerations are discussed in detail.
As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.
Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download PDF [274.68 KB]

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Listings

Member Benefits

FAQs

About Us

© Copyright - Accountable Health Partners - 2024

Website by:  Accelerate Media

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP).  An offer will only be made by means of a confidential private placement memorandum and subscription agreement.